[Form 4] PROCEPT BioRobotics Corporation Insider Trading Activity

Rhea-AI Filing Summary

Insider purchase reported: The Form 4 shows that Frederic Moll, a director of PROCEPT BioRobotics Corp (PRCT), bought 20,000 shares on 08/13/2025 at a weighted average price of $39.2569 per share. After the transactions, he beneficially owns 863,159 shares. The filing notes the shares were acquired in multiple trades with prices ranging from $38.71 to $39.645 and offers to provide a break‑down on request. The form was signed by an attorney‑in‑fact on 08/14/2025.

Positive

• Director purchase recorded: Frederic Moll acquired 20,000 shares on 08/13/2025.
• Ownership increased: Beneficial holdings rose to 863,159 shares following the transaction.
• Transparent pricing: Weighted average price disclosed as $39.2569 with trade range $38.71–$39.645 and an offer to provide detailed allocation on request.

Negative

• None.

Insights

Financial Analyst

TL;DR: A director purchased 20,000 shares at a weighted average ~$39.26, modestly increasing his stake.

The purchase is a straightforward insider buy that increases the reporting persons beneficial ownership to 863,159 shares. The weighted average price and disclosed price range provide transparency on execution. This disclosure does not include company financials or indicate timing rationale; it is a single transaction that investors may interpret as a modest insider signal but not a material corporate event on its own.

Corporate Governance Expert

TL;DR: Director-level open-market purchases reported properly with full price-range disclosure.

The Form 4 appears complete for the reported non-derivative acquisition: reporting person identified, transaction date, code P indicating open-market purchase, number of shares, weighted average price, and post-transaction beneficial ownership. The explanatory footnote clarifies multiple execution prices and offers further disclosure on request, which supports regulatory transparency. No amendments or additional governance actions are indicated.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MOLL FREDERIC H

(Last) (First) (Middle)

C/O PROCEPT BIOROBOTICS CORPORATION

150 BAYTECH DRIVE

(Street)

SAN JOSE CA 95134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2025		P		20,000	A	$39.2569(1)	863,159	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $38.71 to $39.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in this footnote.

Remarks:

	/s/ Jonathan Stone, Attorney-in-Fact for Frederic Moll	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Frederic Moll report for PRCT?

The Form 4 reports a purchase of 20,000 shares of PRCT on 08/13/2025.

How many PRCT shares does Frederic Moll own after the transaction?

He beneficially owns 863,159 shares following the reported purchase.

What price did Frederic Moll pay for the PRCT shares?

The weighted average price was $39.2569 per share; individual trades ranged from $38.71 to $39.645.

When was the Form 4 for PRCT signed and filed?

The signature on the Form 4 is dated 08/14/2025 and the transaction date is 08/13/2025.

Was this purchase executed under a 10b5-1 plan or similar?

The Form indicates transaction code P for open-market purchase; there is no box checked indicating a 10b5-1 plan in the provided content.